We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LPAAW icon
1426
Launch One Acquisition Corp Warrant
LPAAW
$649K
$100K ﹤0.01%
990,000
– –
2024 Q4
7 quarters
IPXGW icon
1427
Inflection Point Acquisition Corp VII Warrant
IPXGW
$100K ﹤0.01%
166,666
+16
+0% +$15
2026 Q2
1 quarter
GTE icon
1428
Gran Tierra Energy
GTE
$317M
$99.4K ﹤0.01%
+10,100
New +$87.9K
2026 Q3
0 quarters
TVACW icon
1429
Texas Ventures Acquisition III Corp Warrants
TVACW
$98.6K ﹤0.01%
450,000
– –
2025 Q4
3 quarters
PLMKW icon
1430
Plum Acquisition Corp IV Warrants
PLMKW
$2.93M
$97.5K ﹤0.01%
250,000
– –
2025 Q1
6 quarters
OYSER icon
1431
Oyster Enterprises II Acquisition Corp Rights
OYSER
$96.9K ﹤0.01%
1,100,000
– –
2025 Q3
4 quarters
PCAPW icon
1432
ProCap Acquisition Corp Warrant
PCAPW
$96.6K ﹤0.01%
333,333
– –
2025 Q3
4 quarters
GTENW icon
1433
Gores Holdings X Warrants
GTENW
$96.2K ﹤0.01%
175,000
– –
2025 Q3
4 quarters
QCOM icon
1434
Qualcomm
QCOM
$171B
$96.1K ﹤0.01%
522
-29,039
-98% -$5.02M
2023 Q3
12 quarters
OACCW icon
1435
Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
$2.78M
$95K ﹤0.01%
95,000
– –
2025 Q1
6 quarters
TENX icon
1436
CALL
Tenax Therapeutics
TENX
$65.1M
$94.5K ﹤0.01%
+50,000
New +$376K
2026 Q3
0 quarters
POLEW icon
1437
Andretti Acquisition Corp II Warrant
POLEW
$1.61M
$93.4K ﹤0.01%
850,000
– –
2024 Q4
7 quarters
GEN icon
1438
Gen Digital
GEN
$18.1B
$92.1K ﹤0.01%
+4,184
New +$116K
2026 Q3
0 quarters
AVAT icon
1439
Avalanche Treasury
AVAT
$32.8M
$91.5K ﹤0.01%
50,000
– –
2026 Q2
1 quarter
MACIW icon
1440
Melar Acquisition Corp I Warrant
MACIW
$798K
$91K ﹤0.01%
742,500
– –
2024 Q4
7 quarters
CRAQR icon
1441
Cal Redwood Acquisition Corp Right
CRAQR
$90.1K ﹤0.01%
600,000
– –
2025 Q2
5 quarters
MRLN icon
1442
Merlin Inc
MRLN
$89.1M
$89.3K ﹤0.01%
47,500
– –
2026 Q2
1 quarter
NPACW icon
1443
New Providence Acquisition Corp III Warrants
NPACW
$599K
$85.6K ﹤0.01%
400,000
– –
2025 Q2
5 quarters
GLND icon
1444
PUT
Greenland Energy
GLND
$85.9M
$85.2K ﹤0.01%
+16,600
New +$34.1K
2026 Q3
0 quarters
SIMAW icon
1445
SIM Acquisition Corp I Warrant
SIMAW
$1.27M
$83.2K ﹤0.01%
490,000
– –
2024 Q4
7 quarters
KFIIR icon
1446
K&F Growth Acquisition Corp II Rights
KFIIR
$82.4K ﹤0.01%
750,000
– –
2025 Q1
6 quarters
SOUL.RT icon
1447
Soulpower Acquisition Corp Rights
SOUL.RT
$82K ﹤0.01%
400,000
– –
2025 Q2
5 quarters
CTNM icon
1448
CALL
Contineum Therapeutics
CTNM
$363M
$80.5K ﹤0.01%
+6,000
New +$89.4K
2026 Q3
0 quarters
DYNCW icon
1449
DELISTED
Dynamix Corp Warrant
DYNCW
$80.4K ﹤0.01%
670,526
– –
2025 Q1
6 quarters
FACTW icon
1450
FACT II Acquisition Corp Warrant
FACTW
$1.22M
$80.2K ﹤0.01%
501,235
– –
2025 Q1
6 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.